Corvid pharmaceuticals

Mumbai, India Founded: 2012 • Age: 14 yrs
Develops and manufactures finished formulations, APIs, and intermediates for the pharmaceutical industry.

About Corvid pharmaceuticals

Corvid pharmaceuticals is a Healthcare company based in Mumbai (India) founded in 2012. It develops and manufactures finished formulations, APIs, and intermediates for the pharmaceutical industry. It operates on a B2B model. Its Indian entity Corvid Pharmaceuticals Private Limited reported revenue of β‚Ή32.7 Lakh. Its focus areas include Pharmaceuticals, Drug Manufacturing and API and Intermediates Production. Similar companies include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed similar companies has raised funding.

Company details

Corvid pharmaceuticals, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api and intermediates production. Develops and manufactures finished formulations, APIs, and intermediates for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

Key Metrics
  • Annual Revenue
    ₹32.7 Lakh

    FY 2022 · -22% YoY

  • Net Profit
    ₹1.4 Lakh

    FY 2022 · 4% margin

  • EBITDA
    ₹2.1 Lakh

    FY 2022 · 6% margin

Board of directors of Corvid Pharmaceuticals Private Limited (Corvid pharmaceuticals)

Corvid Pharmaceuticals Private Limited is the primary company behind Corvid pharmaceuticals. The board of Corvid Pharmaceuticals Private Limited currently have 4 directors; the longest-serving is Swati Rajesh Hedaoo, appointed in 2012. 3 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Swati Rajesh Hedaoo
DIN 05341765
Director28 Aug 201214 yrs 2 moCorvid Pharmaceuticals Private Limited
Vijay Ramchandra Kolhekar
DIN 05341771
Director28 Aug 201214 yrs 2 moCorvid Pharmaceuticals Private Limited
Harendra Singh
DIN 01890498
Director28 Aug 201214 yrs 2 moCorvid Pharmaceuticals Private Limited
Rajesh Chandrakumar Hedaoo
DIN 06872419
Director26 May 201610 yrs 5 moCorvid Pharmaceuticals Private Limited

Financials of Corvid pharmaceuticals

Figures of Corvid Pharmaceuticals Private Limited, the primary company behind Corvid pharmaceuticals, for FY 2022. Revenue was ₹32.7 Lakh (-22% year on year). Net profit was ₹1.4 Lakh (4% margin). EBITDA was ₹2.1 Lakh (6% margin). Revenue has grown at a compounded annual rate of +30% over three years and +15% over five years.

  • ₹32.7 LakhRevenue · FY 2022 · -22% YoY
  • ₹1.4 LakhNet profit · 4% margin
  • ₹2.1 LakhEBITDA · 6% margin
  • ₹1 LakhPaid-up capital
  • +30%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Corvid Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Corvid pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Corvid pharmaceuticals

Corvid pharmaceuticals has 3 listed similar companies in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
indoco.com1947Mumbai, India6,291
APIs manufacturing and formulation services are provided in therapeutic segments.
concordbiotech.com2000Ahmedabad, India1,598
APIs and enzymes are manufactured through fermentation by the CDMO.
bdrpharma.com2003Mumbai, India$88.16M1,864
APIs and finished products are developed and manufactured.
Premium access

Detailed similar companies of Corvid pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Corvid pharmaceuticals

Corvid pharmaceuticals was founded in 2012.

Corvid pharmaceuticals is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

The primary company behind Corvid pharmaceuticals, Corvid Pharmaceuticals Private Limited, reported revenue of β‚Ή32.7 Lakh for FY 2022, down 22% year on year.

Corvid pharmaceuticals, based in Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and api and intermediates production. Develops and manufactures finished formulations, APIs, and intermediates for the pharmaceutical industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.

Corvid pharmaceuticals's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.

Corvid pharmaceuticals operates through Corvid Pharmaceuticals Private Limited.

The legal entities of Corvid pharmaceuticals currently have 4 directors, including Rajesh Chandrakumar Hedaoo, Swati Rajesh Hedaoo, Vijay Ramchandra Kolhekar and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available